Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ATAtossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS)

NASDAQ Capital Market · Currency in USD
$2.60 ▼ -0.12 (-4.41%)
At close: Oct 23, 4:00 PM ET. Market closed.
$2.58 ▼ -0.02 (-0.77%)
After hours: Oct 23, 7:50 PM ET

Summary

Previous Close
$2.72
Open
$2.80
Day's Range
$2.60 – $2.80
52 Week Range
$1.70 – $14.85
Volume
76,996
Avg. Volume
107,752
Market Cap
$25.95M
Beta (5Y Monthly)
1.28
PE Ratio (TTM)
--
EPS (TTM)
-$4.23
Earnings Date
Nov 11, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$42.50

Profile: Atossa Therapeutics, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
16
CEO
Steven C. Quay

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medicines. Their primary focus lies in addressing unmet medical needs in women's oncology, especially breast cancer, along with other conditions, within the United States. The company's flagship therapeutic candidate is oral (Z)-endoxifen.

Earnings

Next report: Wed, Nov 11, 2026
EPS estimate -$0.86
DateEst.Actual
Aug 7, 2026-$1.02-$0.95Beat
May 8, 2026-$1.22-$1.11Beat
Mar 25, 2026-$1.14-$1.19Miss
Nov 12, 2025-$0.98-$1.05Miss
Aug 12, 2025-$0.90-$1.05Miss
May 13, 2025-$0.06-$0.75Miss

Analyst view

Consensus price target
$42.50 ▲ +1,534.6%
Range $10.00 – $75.00
Rating: Buy
Buy 80% · Hold 20% · Sell 0%

Get free alerts on ATOS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.